In vitro safety assessment of papain on human skin: A qualitative Light and Transmission Electron Microscopy (TEM) study

Authors

  • Patrícia Santos Lopes University of São Paulo; School of Pharmaceutical Sciences; Department of Pharmacy
  • Gabriele Wander Ruas Faculty of Pharmaceutical Sciences Oswaldo Cruz
  • André Rolim Baby University of São Paulo; School of Pharmaceutical Sciences; Department of Pharmacy
  • Claudinéia Aparecida Sales de Oliveira Pinto University of São Paulo; School of Pharmaceutical Sciences; Department of Pharmacy
  • Ii-sei Watanabe University of São Paulo; Institute of Biomedical Sciences
  • Maria Valéria Robles Velasco University of São Paulo; School of Pharmaceutical Sciences; Department of Pharmacy
  • Telma Mary Kaneko University of São Paulo; School of Pharmaceutical Sciences; Department of Pharmacy

DOI:

https://doi.org/10.1590/S1516-93322008000100017

Keywords:

Transmission electron microscopy^i1^squalitative analy, Light microscopy^i1^squalitative analy, Stratum corneum, Papain^i1^scosmetic, Human skin^i1^scosmetol

Abstract

Papain is a thiol proteolytic enzyme widely used in dermatology that found applications in wound treatment. Recently, papain was also used as absorption enhancer which can modify the peptide/protein material in the bilayer domain. We investigated papain safety using human skin that was exposed to papain in vitro at different times: 4, 24 and 48 hours. The samples were examined using Light and Transmission Electron Microscopy (TEM) to study of the mechanisms involved in enhancer-skin interaction. After 24 hours, changes occurred in corneosomes. However, samples of 48 hours did not show major changes in agreement with the control. These findings indicated that papain could be used safely onto the skin.

Downloads

Download data is not yet available.

Downloads

Published

2008-03-01

Issue

Section

Original Papers

How to Cite

In vitro safety assessment of papain on human skin: A qualitative Light and Transmission Electron Microscopy (TEM) study. (2008). Revista Brasileira De Ciências Farmacêuticas, 44(1), 151-156. https://doi.org/10.1590/S1516-93322008000100017